Are we overestimating the loss of beta cells in type 2 diabetes?-Reference-Cited by-同舟云学术

Are we overestimating the loss of beta cells in type 2 diabetes?

Published:2013-11-15 Issue:2 Volume:57 Page:362-365
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Marselli Lorella,Suleiman Mara,Masini Matilde,Campani Daniela,Bugliani Marco,Syed Farooq,Martino Luisa,Focosi Daniele,Scatena Fabrizio,Olimpico Francesco,Filipponi Franco,Masiello Pellegrino,Boggi Ugo,Marchetti Piero

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-013-3098-3.pdf

Reference17 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577–1596

2. Meier JJ (2008) Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 51:703–713

3. Ahrén B (2005) Type 2 diabetes, insulin secretion and beta-cell mass. Curr Mol Med 5:275–286

4. Hanley NA, Hanley KP, Miettinen PJ, Otonkoski T (2008) Weighing up beta-cell mass in mice and humans: self-renewal, progenitors or stem cells? Mol Cell Endocrinol 288:79–85

5. Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?;Peptides;2024-09

2. Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus;Clinical Diabetes and Endocrinology;2024-08-10

3. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes;Biomedicine & Pharmacotherapy;2024-08

4. Exercise induces tissue-specific adaptations to enhance cardiometabolic health;Cell Metabolism;2024-02

5. Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes;Textbook of Diabetes;2024-01-12